Intriguingly, increased Sox2 levels also significantly correlated with lower PR expression than in primary tumours, as observed in the resistance models examined, suggesting that the ER signalling pathway is compromised during development of tamoxifen resistance. The gene discussed is ESR1; the disease is neoplasm.